Royalty Pharma plc (RPRX)
USD 30.85
(-0.58%)
USD 30.85
(-0.58%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.79 Billion USD | -19.61% |
| 2022 | 2.23 Billion USD | -1.54% |
| 2021 | 2.26 Billion USD | 11.44% |
| 2020 | 2.03 Billion USD | 155.86% |
| 2019 | 794.93 Million USD | -52.08% |
| 2018 | 1.65 Billion USD | 6.03% |
| 2017 | 1.56 Billion USD | -16.66% |
| 2016 | 1.87 Billion USD | 13.62% |
| 2015 | 1.65 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -15.62 Million USD | -103.01% |
| 2024 Q2 | 531.26 Million USD | 3500.76% |
| 2023 Q1 | 565.16 Million USD | 0.91% |
| 2023 Q4 | 519.48 Million USD | 100.44% |
| 2023 Q2 | 296.97 Million USD | -47.45% |
| 2023 FY | 1.79 Billion USD | -19.61% |
| 2023 Q3 | 259.17 Million USD | -12.73% |
| 2022 FY | 2.23 Billion USD | -1.54% |
| 2022 Q4 | 560.07 Million USD | 108.67% |
| 2022 Q3 | 268.4 Million USD | -37.62% |
| 2022 Q2 | 430.24 Million USD | -22.67% |
| 2022 Q1 | 556.37 Million USD | 79.94% |
| 2021 Q3 | 579.97 Million USD | 5.6% |
| 2021 Q4 | 309.19 Million USD | -46.69% |
| 2021 Q1 | 567.35 Million USD | 28.46% |
| 2021 FY | 2.26 Billion USD | 11.44% |
| 2021 Q2 | 549.23 Million USD | -3.19% |
| 2020 Q3 | 533.2 Million USD | 5.54% |
| 2020 Q1 | 412.86 Million USD | 189.43% |
| 2020 FY | 2.03 Billion USD | 155.86% |
| 2020 Q4 | 441.65 Million USD | -17.17% |
| 2020 Q2 | 505.19 Million USD | 22.36% |
| 2019 Q1 | 384.85 Million USD | 0.0% |
| 2019 FY | 794.93 Million USD | -52.08% |
| 2019 Q4 | -461.67 Million USD | -235.02% |
| 2019 Q3 | 341.93 Million USD | -11.28% |
| 2019 Q2 | 385.39 Million USD | 0.14% |
| 2018 FY | 1.65 Billion USD | 6.03% |
| 2017 FY | 1.56 Billion USD | -16.66% |
| 2016 FY | 1.87 Billion USD | 13.62% |
| 2015 FY | 1.65 Billion USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | -1389.033% |
| Jaguar Health, Inc. | 7.72 Million USD | -23124.987% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 270265.361% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 35878060.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -18.184% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -1397.998% |
| ContextLogic Inc. | 59 Million USD | -2940.505% |
| MiMedx Group, Inc. | 266.84 Million USD | -572.267% |
| MEI Pharma, Inc. | 49.32 Million USD | -3536.747% |
| AlloVir, Inc. | -398 Thousand USD | 450828.141% |
| Novavax, Inc. | 639.93 Million USD | -180.324% |
| Aptorum Group Limited | -1.11 Million USD | 161032.745% |
| Ardelyx, Inc. | 106.66 Million USD | -1581.869% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -645.175% |
| Psyence Biomedical Ltd. | -240.00 USD | 747457600.0% |
| Vaxcyte, Inc. | -75 Million USD | 2491.864% |
| Precigen, Inc. | 106 Thousand USD | -1692256.604% |
| Pharming Group N.V. | 220.1 Million USD | -715.023% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -348229.709% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -177689.693% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -1534.204% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 1088.875% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 347252.76% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 1485.036% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 4057.855% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 8258.903% |
| Acelyrin, Inc. | -115 Thousand USD | 1560011.304% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 314267.776% |
| Senti Biosciences, Inc. | -2.68 Million USD | 66961.647% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -44182.844% |
| AbCellera Biologics Inc. | 38.02 Million USD | -4617.68% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 37488.454% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -1494815.0% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -6058.461% |
| Chimerix, Inc. | 324 Thousand USD | -553572.222% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -361572.984% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 2187780.488% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 5855.639% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 364713.415% |
| Elevation Oncology, Inc. | -39 Thousand USD | 4599838.462% |
| Alkermes plc | 1.37 Billion USD | -30.496% |
| Fortress Biotech, Inc. | 57.85 Million USD | -3000.786% |
| Fortress Biotech, Inc. | 57.85 Million USD | -3000.786% |
| Agenus Inc. | 139.61 Million USD | -1184.889% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -10721.608% |
| Dyadic International, Inc. | 922.95 Thousand USD | -194264.201% |
| ImmuCell Corporation | 4.39 Million USD | -40704.871% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -8417.63% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 1790.395% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 1026105.045% |
| Immix Biopharma, Inc. | -5468.00 USD | 32807305.56% |
| Incyte Corporation | 3.44 Billion USD | 47.862% |
| IO Biotech, Inc. | -756 Thousand USD | 237388.095% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 3929.924% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 13529.543% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 4059794.94% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 1926.464% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 3261732.727% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -223578.055% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 340498.102% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -6004.393% |
| NextCure, Inc. | -3.68 Million USD | 48794.3% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -9320.249% |
| Onconetix, Inc. | -1.12 Million USD | 159251.322% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 6292.688% |
| Opthea Limited | 21.72 Thousand USD | -8259098.895% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 3129392.119% |
| PureTech Health plc | -1.6 Million USD | 112008.796% |
| Pyxis Oncology, Inc. | -2 Million USD | 89794.9% |
| Seer, Inc. | 7.02 Million USD | -25428.647% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 17848055.427% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -22691.234% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 45606.752% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -422989.151% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -1623.262% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -1226.171% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 1950.333% |
| ChromaDex Corporation | 50.78 Million USD | -3432.686% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 773331.897% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 2411.784% |
| CRISPR Therapeutics AG | 240.95 Million USD | -644.492% |
| Precision BioSciences, Inc. | 40.47 Million USD | -4332.442% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 1927.469% |
| Innoviva, Inc. | 261.06 Million USD | -587.146% |
| Summit Therapeutics Inc. | -2.05 Million USD | 87607.22% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -40875.286% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -8226.285% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 1514052.958% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 1251939.136% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -294464.532% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -471.902% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -69593.007% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 3535571.029% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 25373.288% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 378124.845% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 17249119.231% |
| Soligenix, Inc. | 97.31 Thousand USD | -1843368.878% |
| Century Therapeutics, Inc. | -10.8 Million USD | 16696.336% |
| Kura Oncology, Inc. | -849 Thousand USD | 211395.406% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 2773.31% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 1220438.776% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -1711.305% |
| Autolus Therapeutics plc | -4.86 Million USD | 36958.393% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -4234.553% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 1067896.429% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -1793.836% |
| GRI Bio, Inc. | 10.84 Million USD | -16447.348% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -70526.295% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 20750.374% |
| IGM Biosciences, Inc. | -211.66 Million USD | 947.538% |
| INmune Bio, Inc. | 155 Thousand USD | -1157253.548% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -2796.233% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 119193.721% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 276742.291% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 6128056.548% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -446143.284% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 89974.649% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 573230.351% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -1799.089% |
| Verastem, Inc. | -62 Thousand USD | 2893483.871% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -73571.376% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 687417.241% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -59163.231% |
| Histogen Inc. | 3.76 Million USD | -47496.126% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -311243.871% |
| Surrozen, Inc. | -27.23 Million USD | 6687.947% |
| Organovo Holdings, Inc. | -5.38 Million USD | 33388.143% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 148986.03% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 7094.572% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -8846.23% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 90601009.091% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -29470.935% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 2672334.884% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -1058.916% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -1230282.716% |
| Apollomics, Inc. | 127 Thousand USD | -1412418.11% |
| Amarin Corporation plc | 165.54 Million USD | -983.658% |
| Mesoblast Limited | -9.81 Million USD | 18377.106% |
| Turnstone Biologics Corp. | 16.5 Million USD | -10768.157% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 1723.599% |
| Synaptogenix, Inc. | -6347.00 USD | 28263815.141% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 3517547.059% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -1011.702% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | -2.062% |
| Better Therapeutics, Inc. | -2.72 Million USD | 65834.628% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 1699.396% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -430.612% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 15725012.342% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 28756.518% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 162004.152% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -24413.498% |
| Insmed Incorporated | 239.63 Million USD | -648.596% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -50036.892% |
| OmniAb, Inc. | 14.66 Million USD | -12130.845% |
| Alector, Inc. | -95.05 Million USD | 1987.261% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -1328.024% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 4227.414% |
| Zai Lab Limited | 170.9 Million USD | -949.659% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -2090.967% |
| Aura Biosciences, Inc. | -1.29 Million USD | 138624.942% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -1379821.538% |
| Immunic, Inc. | -111 Thousand USD | 1616224.324% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -11215.113% |
| Veracyte, Inc. | 248.14 Million USD | -622.915% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 125.667% |
| FibroGen, Inc. | 128.9 Million USD | -1291.654% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 318067121.277% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 15475.981% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 47.217% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -461056.298% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -404.833% |
| TG Therapeutics, Inc. | 219.1 Million USD | -718.728% |
| Galecto, Inc. | -830 Thousand USD | 216232.289% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 129623.321% |
| Fortrea Holdings Inc. | 424 Million USD | -323.089% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 2181.885% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 316484.127% |
| XBiotech Inc. | -1.74 Million USD | 102961.124% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 162004.152% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 3960.253% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 2474.954% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -2343.903% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -10576.058% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -361.109% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 3713.306% |
| Vaxxinity, Inc. | -2.23 Million USD | 80399.821% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -449.011% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 15941.779% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -7236.706% |
| NexImmune, Inc. | -1.02 Million USD | 175119.22% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -33220233.333% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 25346.058% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 84.127% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 2684491.04% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 50618.108% |
| Ainos, Inc. | -253.73 Thousand USD | 707102.243% |
| Pluri Inc. | 322 Thousand USD | -557011.18% |
| Prothena Corporation plc | -129.2 Million USD | 1488.455% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -3457.631% |
| Celularity Inc. | 6.75 Million USD | -26456.595% |
| Rallybio Corporation | -150 Thousand USD | 1196032.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 5601.573% |
| MeiraGTx Holdings plc | 287 Thousand USD | -624951.568% |
| Omeros Corporation | -69.77 Million USD | 2670.828% |
| Humacyte, Inc. | -76.55 Million USD | 2443.433% |
| Immunocore Holdings plc | 248.39 Million USD | -622.207% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 11926.08% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -2775.666% |
| Blueprint Medicines Corporation | 236.58 Million USD | -658.25% |
| CalciMedica, Inc. | -58 Thousand USD | 3093027.586% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 125899.299% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -6074.146% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 63176.582% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 5912.078% |
| Pulmatrix, Inc. | -8.22 Million USD | 21923.577% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 153424.615% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 449698.496% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 549.831% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -64531.348% |
| Cytokinetics, Incorporated | -322.59 Million USD | 656.087% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -207983.47% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 526169.795% |
| Vor Biopharma Inc. | -3.49 Million USD | 51471.649% |
| Roivant Sciences Ltd. | 109.23 Million USD | -1542.237% |
| Evogene Ltd. | 1.39 Million USD | -128127.162% |
| ProKidney Corp. | -3.16 Million USD | 56707.7% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 4185.211% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -26061.558% |
| CorMedix Inc. | -205.56 Thousand USD | 872779.775% |
| BioLineRx Ltd. | 1.1 Million USD | -161804.152% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 2380.253% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 5436154.545% |
| Atai Life Sciences N.V. | -5000.00 USD | 35878060.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 1472209.569% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 1868743.75% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 129250.324% |
| Sagimet Biosciences Inc. | 2 Million USD | -89594.9% |
| MediciNova, Inc. | 979.7 Thousand USD | -183005.935% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 2227.513% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1897300.571% |
| GeoVax Labs, Inc. | -20.72 Million USD | 8757.489% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -633.596% |
| Biomea Fusion, Inc. | -4.2 Million USD | 42801.69% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -105.643% |
| Mereo BioPharma Group plc | 7.42 Million USD | -24056.989% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 578776.774% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 14949250.0% |
| Absci Corporation | -41.84 Million USD | 4386.597% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 35878060.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 2448.864% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 72993.052% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -739.309% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 190737.407% |
| Allakos Inc. | -6.14 Million USD | 29311.822% |
| Imunon, Inc. | -720 Thousand USD | 249250.77% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 2700.003% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -276.953% |
| BioAtla, Inc. | -103.73 Million USD | 1829.375% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 15725012.342% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 1007907.865% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 838.78% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 576916.077% |
| XOMA Corporation | 3.86 Million USD | -46362.005% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 2659.603% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -12025.848% |
| aTyr Pharma, Inc. | -2.38 Million USD | 75221.357% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -14297.255% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 6185955.172% |
| Viridian Therapeutics, Inc. | -1 Million USD | 178066.071% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -13799215284.615% |
| Akari Therapeutics, Plc | -4000.00 USD | 44847550.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -181.664% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -921227.321% |
| UroGen Pharma Ltd. | 73.35 Million USD | -2345.602% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 6820.229% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -15451217.829% |
| Orgenesis Inc. | -5.72 Million USD | 31434.463% |
| Entera Bio Ltd. | -56 Thousand USD | 3203489.286% |
| GH Research PLC | -315 Thousand USD | 569591.429% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 949252.381% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 341794.857% |
| Xencor, Inc. | -85.26 Million USD | 2204.032% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 811903.038% |
| Replimune Group, Inc. | -2.65 Million USD | 67666.78% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 179268.348% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -908.692% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -921227.321% |
| Portage Biotech Inc. | -54 Thousand USD | 3322133.333% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1897300.571% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 475935.013% |
| OncoCyte Corporation | 413 Thousand USD | -434257.869% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 39908843.048% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 808062262.162% |
| Purple Biotech Ltd. | -196 Thousand USD | 915354.082% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -19903.323% |
| scPharmaceuticals Inc. | 9.78 Million USD | -18238.765% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 17274.776% |
| HilleVax, Inc. | -2.15 Million USD | 83304.917% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 1849479.381% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 11956231.698% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 268647.605% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 7799656.522% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 23899110.946% |
| Savara Inc. | -44.26 Million USD | 4152.908% |
| Curis, Inc. | 9.81 Million USD | -18184.558% |
| Daré Bioscience, Inc. | 2.76 Million USD | -64672.838% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 1437656.496% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 103853.499% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 786897.368% |
| BeiGene, Ltd. | 2.07 Billion USD | 13.708% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 64261.737% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 548.852% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -3064.511% |
| Erasca, Inc. | -3.73 Million USD | 48168.006% |
| bluebird bio, Inc. | -4.03 Million USD | 44613.598% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 6357382.586% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 5.801% |
| DBV Technologies S.A. | 15.72 Million USD | -11305.76% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 6357382.586% |
| Moderna, Inc. | 2.15 Billion USD | 16.756% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 196154.426% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -22306.92% |
| Molecular Templates, Inc. | 50.39 Million USD | -3459.675% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 334782.463% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -1240.851% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 28931.533% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 4659.637% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 1714.263% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 50097.157% |
| MacroGenics, Inc. | 50.52 Million USD | -3450.375% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 29517.809% |
| Prime Medicine, Inc. | -147.9 Million USD | 1312.872% |
| Aditxt, Inc. | -111.66 Thousand USD | 1606671.736% |
| Adagene Inc. | 18.11 Million USD | -9804.751% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -367502.049% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -1179.51% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -1036.558% |
| SciSparc Ltd. | 2.19 Million USD | -81589.344% |
| Vericel Corporation | 135.57 Million USD | -1223.168% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 7161655.352% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 5790229.753% |
| Generation Bio Co. | -73.91 Million USD | 2527.106% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 410602.975% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -3184.385% |
| Invivyd, Inc. | -2.02 Million USD | 88556.509% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 696.294% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 1734373.671% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -1761.508% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -1725.144% |
| ADMA Biologics, Inc. | 88.21 Million USD | -1933.483% |
| Clene Inc. | 533 Thousand USD | -336466.229% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -7340.725% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 187550.157% |
| GeoVax Labs, Inc. | -20.72 Million USD | 8757.489% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -90136.318% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 923285.945% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -3501.843% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 25394.67% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 214681.1% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -2050.57% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -2453530.047% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -3274.399% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 1135.81% |
| Trevena, Inc. | 1.45 Million USD | -123191.959% |
| Surrozen, Inc. | -27.23 Million USD | 6687.947% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 508286.402% |
| Cingulate Inc. | -582.91 Thousand USD | 307844.486% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 5786867.742% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 9206.543% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 23697563.672% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 203720.658% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -163.535% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 181668.623% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 3184044.482% |
| Kronos Bio, Inc. | 1.37 Million USD | -130650.583% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 3442.709% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 614448.63% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 367465.67% |
| ImmunityBio, Inc. | -17.89 Million USD | 10127.378% |
| Korro Bio, Inc. | -3.63 Million USD | 49518.678% |
| Kineta, Inc. | 5.43 Million USD | -32918.553% |
| BioVie Inc. | -229.37 Thousand USD | 782174.053% |
| Codexis, Inc. | 57.33 Million USD | -3028.855% |
| Celularity Inc. | 6.75 Million USD | -26456.595% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -44602.168% |
| Celcuity Inc. | -142.77 Thousand USD | 1256577.461% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -3545853.746% |
| Cibus, Inc. | 1.42 Million USD | -126053.165% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 479751.872% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 7927.122% |
| IN8bio, Inc. | -2.5 Million USD | 71827.229% |
| Kodiak Sciences Inc. | -25.94 Million USD | 7013.701% |
| Annexon, Inc. | -3.26 Million USD | 55009.642% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 87864.09% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 4398.1% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -280196.563% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -130.426% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -937.205% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 94515.684% |
| Arcellx, Inc. | 108.27 Million USD | -1556.737% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 5642.025% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -2164.908% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 8580.985% |
| Moolec Science SA | -143.3 Thousand USD | 1251904.194% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 4339.09% |
| Geron Corporation | -123.5 Million USD | 1552.514% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -54475.54% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 2659.421% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 49665050.166% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -775166.972% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 1710.119% |
| Humacyte, Inc. | -76.55 Million USD | 2443.433% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 189095.695% |
| 89bio, Inc. | -273 Thousand USD | 657205.495% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 142812.649% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 211644.575% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 1458553.659% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -160212.601% |
| Notable Labs, Ltd. | 113 Thousand USD | -1587420.354% |
| Liquidia Corporation | 14.6 Million USD | -12186.973% |
| Mustang Bio, Inc. | -2.22 Million USD | 80724.629% |
| Immunovant, Inc. | -231 Thousand USD | 776679.221% |
| Quantum-Si incorporated | 488 Thousand USD | -367502.049% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 3328.816% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 5979760.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -96242.535% |
| Acasti Pharma Inc. | -11 Thousand USD | 16308263.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 876810.146% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 276742.291% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 1170.907% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -158011.195% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 470939.37% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 91718.897% |
| PepGen Inc. | -1.18 Million USD | 151611.655% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 1412618.11% |
| United Therapeutics Corporation | 2.07 Billion USD | 13.338% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 7934.642% |
| Solid Biosciences Inc. | -76.56 Million USD | 2443.035% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 2172336.417% |
| Immuneering Corporation | -764.13 Thousand USD | 234860.999% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -2707098.479% |
| Belite Bio, Inc | -399 Thousand USD | 449698.496% |
| XOMA Corporation | 3.86 Million USD | -46362.005% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 9053.374% |
| Bionomics Limited | -434.44 Thousand USD | 413013.368% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 167129.609% |
| uniQure N.V. | 2.21 Million USD | -80888.623% |
| Cassava Sciences, Inc. | -89.42 Million USD | 2106.081% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 2048.428% |
| Forte Biosciences, Inc. | -9000.00 USD | 19932300.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 214938.084% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 410602.975% |
| Altimmune, Inc. | -65.37 Million USD | 2844.096% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -395.511% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 167129.609% |
| Compugen Ltd. | 31.45 Million USD | -5603.062% |
| Peak Bio, Inc. | 367.76 Thousand USD | -487678.47% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -7217.254% |
| Benitec Biopharma Inc. | 108 Thousand USD | -1660916.667% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 2299969.231% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 149218.703% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 98557.629% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 1507577.311% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 149218.703% |
| Instil Bio, Inc. | -4.75 Million USD | 37818.629% |
| argenx SE | 1.1 Billion USD | -61.834% |
| Immunome, Inc. | -8.9 Million USD | 20240.317% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 95015.238% |
| Verona Pharma plc | -679.62 Thousand USD | 264054.481% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 1025184.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | 75315.849% |
| CervoMed Inc. | -1.29 Million USD | 138771.966% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 74628.376% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 37652.816% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -72498.057% |
| Moolec Science SA | -143.3 Thousand USD | 1251904.194% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 439748.555% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 67248.763% |
| AnaptysBio, Inc. | 14.78 Million USD | -12036.513% |
| Design Therapeutics, Inc. | -537 Thousand USD | 334159.218% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 420216.628% |
| NeurAxis, Inc. | 2.15 Million USD | -83077.756% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -83492.637% |
| Lumos Pharma, Inc. | 2 Million USD | -89282.063% |
| Achilles Therapeutics plc | -4.73 Million USD | 38015.806% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 1025184.571% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 1697661.391% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -5566.357% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -207983.47% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 173927.326% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 4038.478% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -4171755.814% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 218335.766% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 13633615.732% |
| Palisade Bio, Inc. | 246 Thousand USD | -729126.829% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 5436154.545% |
| Beam Therapeutics Inc. | -59.67 Million USD | 3106.264% |
| Neurogene Inc. | -3.26 Million USD | 55093.807% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -1187.471% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 48688.787% |
| Sesen Bio, Inc. | 40 Million USD | -4384.745% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 604106.061% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 44646.35% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 18852.854% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -12640.753% |
| Athira Pharma, Inc. | -969 Thousand USD | 185228.793% |
| Vaccinex, Inc. | -16 Million USD | 11309.06% |
| HCW Biologics Inc. | -574.82 Thousand USD | 312177.784% |
| XOMA Corporation | 3.86 Million USD | -46362.005% |
| Nektar Therapeutics | 53.47 Million USD | -3254.46% |
| Arvinas, Inc. | 71.8 Million USD | -2398.465% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 2249.384% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 2957.663% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 557211.18% |
| Rezolute, Inc. | -36 Thousand USD | 4983150.0% |
| Clene Inc. | 533 Thousand USD | -336466.229% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 139711782.243% |
| BeyondSpring Inc. | 1.75 Million USD | -102349.914% |
| Synlogic, Inc. | -1.92 Million USD | 93337.942% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 4848472.973% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 28430.67% |
| Peak Bio, Inc. | 367.76 Thousand USD | -487678.47% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 9559.991% |
| Krystal Biotech, Inc. | 47.6 Million USD | -3668.297% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -1171.448% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -35599.463% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 69383.363% |
| MannKind Corporation | 136.19 Million USD | -1217.193% |
| Ikena Oncology, Inc. | -50.49 Million USD | 3652.836% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -1548.591% |
| Gossamer Bio, Inc. | -4.38 Million USD | 41009.875% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 711964.286% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 35878060.0% |
| Legend Biotech Corporation | 140.92 Million USD | -1172.909% |
| Mural Oncology plc | -2.56 Million USD | 69983.054% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 325671.325% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 1793998.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -8543.625% |
| REGENXBIO Inc. | 53.02 Million USD | -3282.862% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 33587.283% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 932600.585% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 103673.788% |
| Vaxart, Inc. | -60.76 Million USD | 3052.287% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 682761.542% |
| Cellectis S.A. | 18 Thousand USD | -9966000.0% |
| Longeveron Inc. | 221 Thousand USD | -811618.552% |
| Repare Therapeutics Inc. | -80.07 Million USD | 2340.412% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -64.127% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 138731.994% |
| Revolution Medicines, Inc. | -399.66 Million USD | 548.852% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 5125522.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -3660916.327% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 79.158% |
| Denali Therapeutics Inc. | -93.34 Million USD | 2021.793% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 7161655.352% |
| Veru Inc. | 7.56 Million USD | -23610.218% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 1188111.921% |
| Cingulate Inc. | -582.91 Thousand USD | 307844.486% |
| Passage Bio, Inc. | -3.72 Million USD | 48310.105% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 14894636.699% |
| Exicure, Inc. | -1.42 Million USD | 126164.512% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 468480.679% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -66266.926% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 350009.397% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -2533.206% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 1199173.573% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 3129.926% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -458697.442% |
| OmniAb, Inc. | 14.66 Million USD | -12130.845% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -8872.63% |
| Lipocine Inc. | -2.85 Million USD | 63025.729% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 97435.757% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 31544.312% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 119193.721% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -2281.829% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 2759943.077% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -2028.094% |
| Ocugen, Inc. | -33.53 Million USD | 5449.012% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 56833.017% |
| Q32 Bio Inc. | 578 Thousand USD | -310262.976% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 677042.642% |
| Alumis Inc. Common Stock | -1.28 Million USD | 139811.682% |
| Equillium, Inc. | 35.95 Million USD | -4888.87% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 105190.685% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -358193.038% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 43393859.071% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 692724.71% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -424278.3% |
| Dominari Holdings Inc. | 2.03 Million USD | -87879.304% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 977855.613% |
| vTv Therapeutics Inc. | -13.59 Million USD | 13295.278% |
| Bio-Techne Corporation | 773.07 Million USD | -132.047% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -10257.977% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -289.313% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 153555.774% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 7580.809% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -15236.394% |
| Nkarta, Inc. | -5.86 Million USD | 30665.65% |
| BioCardia, Inc. | -7.24 Million USD | 24846.834% |
| Iterum Therapeutics plc | -1.75 Million USD | 102608.457% |